SKIDA1 expression may predict those rearrangements in most subtypes of acute leukemia, while LAMP5 presents good performance to point out KMT2A-r in B-ALL and ALAL, including the KMT2A-USP2 fusion. This evidence concerns the gene USP2 and precursor B-cell acute lymphoblastic leukemia.